Financial statements Bristol-Myers Squibb Polska
Cash inflows of BRISTOL-MYERS SQUIBB POLSKA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | - | - | - | -50 327 851,52 | -47 672 019,97 | -13 046 433,51 |
| Net cash flow from investing activities | - | - | - | 51 260 717,47 | 15 116 810,84 | 355 959,03 |
| Net cash flow from financial activities | - | - | - | -20 261,51 | 37 398 060,72 | 32 393 101,50 |
| Total net cash flow | - | - | - | 912 604,44 | 4 842 851,59 | 19 702 627,02 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.